Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Coart

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Trials (London, England)|June 24, 2017
The impact of data errors on the outcome of randomized clinical trialsMarc Buyse, Pierre Squifflet, Elisabeth Coart, et al.
Journal of the National Cancer Institute|June 23, 2018
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Everardo D Saad, John R Zalcberg, Julien Péron, et al.
Cancers|September 28, 2023
Trial Design for Cancer Immunotherapy: A Methodological ToolkitEverardo D Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas, et al.
Statistics in Medicine|October 23, 2023
Minimization in randomized clinical trialsElisabeth Coart, Perrine Bamps, Emmanuel Quinaux, et al.
BMC Medical Research Methodology|October 5, 2022
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationCorinne Jamoul, Laurence Collette, Elisabeth Coart, et al.
Future Oncology (London, England)|August 23, 2023
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancerVéronique Debien, Virginie Adam, Elisabeth Coart, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2020
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitorsElisabeth Coart, Stefan Suciu, Pierre Squifflet, et al.
Journal of Alzheimer'S Disease : JAD|November 1, 2015
Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease PathologyAndrea F N Rosenberger, Riet Hilhorst, Elisabeth Coart, et al.
Clinical Colorectal Cancer|September 28, 2024
Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsIrene Assaf, Giacomo Bregni, Geraldine Anthoine, et al.
Journal of the National Cancer Institute|December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyRichard M Goldberg, Richard Adams, Marc Buyse, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Trials (London, England)|June 24, 2017
The impact of data errors on the outcome of randomized clinical trialsMarc Buyse, Pierre Squifflet, Elisabeth Coart, et al.
Journal of the National Cancer Institute|June 23, 2018
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Everardo D Saad, John R Zalcberg, Julien Péron, et al.
Cancers|September 28, 2023
Trial Design for Cancer Immunotherapy: A Methodological ToolkitEverardo D Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas, et al.
Statistics in Medicine|October 23, 2023
Minimization in randomized clinical trialsElisabeth Coart, Perrine Bamps, Emmanuel Quinaux, et al.
BMC Medical Research Methodology|October 5, 2022
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationCorinne Jamoul, Laurence Collette, Elisabeth Coart, et al.
Future Oncology (London, England)|August 23, 2023
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancerVéronique Debien, Virginie Adam, Elisabeth Coart, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2020
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitorsElisabeth Coart, Stefan Suciu, Pierre Squifflet, et al.
Journal of Alzheimer'S Disease : JAD|November 1, 2015
Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease PathologyAndrea F N Rosenberger, Riet Hilhorst, Elisabeth Coart, et al.
Clinical Colorectal Cancer|September 28, 2024
Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsIrene Assaf, Giacomo Bregni, Geraldine Anthoine, et al.
Journal of the National Cancer Institute|December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyRichard M Goldberg, Richard Adams, Marc Buyse, et al.
Pageof 2